Charleston, SC -- (SBWIRE) -- 09/02/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Vu1 Corporation (OTCMKTS:VUOC), Lithium Exploration Group Inc (OTCMKTS:LEXG), Titan Pharmaceuticals, Inc. (OTCBB:TTNP), El Capitan Precious Metals, Inc. (OTCBB:ECPN)
Vu1 Corporation (OTCMKTS:VUOC) remained a bull for the day as it reported the upward momentum of +31.85% and closed at $1.78 after gaining total volume of 48,109 shares. Its introductory price for the day was $1.36. So far, the company’s stock is up +28.99% in the three months period. In the last 6 months of trade it reported a gain of +7.88%.
Vu1 Corporation engages in designing, developing, and selling a line of mercury free, energy efficient lighting products based on its proprietary Electron Stimulated Luminescence technology.
Will VUOC Continue To Move Higher? Find Out Here
Lithium Exploration Group Inc (OTCMKTS:LEXG) reported the decline of -2.96% and closed at $ 0.131 with the total traded volume of 540,424 shares. The stock's opening price was $ 0.14. The company has a total market capitalization of $ 6.20 million.
The 52-week price range of the stock remained $0.09 - $0.41, while during last trade its minimum price was $0.13 and it gained its highest price of $0.14. Company's last 5 days shows a down turn with a decline of -21.56%. Lithium Exploration Group, Inc., an exploration stage company, engages in the acquisition, exploration, and development of resource properties in Canada. The company explores for lithium and potassium, as well as for calcium, magnesium, iodine, and bromine.
Has LEXG Found The Bottom And Ready To Gain Momentum? Find Out Here
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) ended its day with the declining stream with the plunge of -1.93% and closed at the price of $0.598 after opening at $0.60. Stock traded during its last trading session with the total volume of 75,559 shares, as compared to its average volume of 202,733 shares.
During the previous session, the company’s minimum price was $0.58, while it touched its highest price for the day at $0.61. TTNP’s beta value stands at 9.69 points. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
Why Should Investors Buy TTNP After the Recent Fall? Just Go Here and Find Out
El Capitan Precious Metals, Inc. (OTCBB:ECPN) reported the increase of +18.06%, to close at $0.127, with the overall traded volume of 242,547 shares.
So far, in the past three months, the stock is down -27.14%. The 52-week range for the stock is $0.07 and $0.52 and during the previous trading session the stock touched its highest price at $0.13. Its introductory price for the day was $0.11. El Capitan Precious Metals, Inc., an exploration stage company, engages in the exploration of precious metals and other minerals in Scottsdale, Arizona. It primarily holds interest in the El Capitan gold-silver property located near Capitan, New Mexico.
What was the Moving Force behind ECPN On Bullish Run? Read This Research Report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)